Long-term remission from life-threatenin
β
Eugene R. Ahn; Gabriella Lander; Carlos J. Bidot; Wenche Jy; Yeon S. Ahn
π
Article
π
2005
π
John Wiley and Sons
π
English
β 61 KB
π 1 views
Rituximab, a chimeric monoclonal CD20 antibody, is useful in the treatment of B-cell lymphomas and certain autoimmune diseases. We report a successful outcome of rituximab for life threatening hypercoagulable state associated with lupus anticoagulant (LA). A 30-year-old woman initially presented 10